Kolexia
Moine Pierre
Anesthesie-réanimation
Hôpital Raymond-Poincaré
Garches, France
57 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Sepsie Maladie grave Choc Pneumopathie infectieuse Choc septique Syndrome de détresse respiratoire de l'adulte Infections à coronavirus Pneumopathie virale

Industries

PROVEPHARM
4 collaboration(s)
Dernière en 2021
Pfizer
2 collaboration(s)
Dernière en 2023
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

REMAP-CAP: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Essai Clinique (UMC Utrecht)   25 février 2024
Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.
The Lancet. Respiratory medicine   01 février 2024
Antibiotics in anesthesia and critical care.
Annals of translational medicine   13 décembre 2023
Corticosteroids and mortality in septic shock complicated by the acute respiratory distresss syndrome
Proceedings of Reanimation 2023, the French Intensive Care Society International Congress   14 juin 2023
Continuous renal replacement therapy with oxiris filter in critically ill covid-19 patients
Proceedings of Reanimation 2023, the French Intensive Care Society International Congress   14 juin 2023
Hydrocortisone and fludrocortisone for community acquired pneumonia
Proceedings of Reanimation 2023, the French Intensive Care Society International Congress   14 juin 2023
renal replacement therapy with oXiris filter in critically ill COVID-19 patients
42nd International Symposium on Intensive Care & Emergency Medicine   21 mars 2023
Effect of an enteral amino acid blend on muscle and gut functionality in critically ill patients: a proof-of-concept randomized controlled trial.
Critical care (London, England)   17 novembre 2022
Remdesivir for Patients Hospitalized with COVID-19 Severe Pneumonia: A National Cohort Study (Remdeco-19).
Journal of clinical medicine   04 novembre 2022
Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis.
Frontiers in immunology   29 septembre 2022